These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11961436)

  • 1. Diffuse infiltrative lung disease associated with flecainide. Report of two cases.
    Pesenti S; Lauque D; Daste G; Boulay V; Pujazon MC; Carles P
    Respiration; 2002; 69(2):182-5. PubMed ID: 11961436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM; Ward Platt MP
    Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of flecainide safety in patients with supraventricular arrhythmias.
    Wehling M
    Arzneimittelforschung; 2002; 52(7):507-14. PubMed ID: 12189773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECGs in the ED.
    Tanel RE
    Pediatr Emerg Care; 2008 Nov; 24(11):803-4. PubMed ID: 19018229
    [No Abstract]   [Full Text] [Related]  

  • 6. Flecainide induced ventricular fibrillation in a neonate.
    Ackland F; Singh R; Thayyil S
    Heart; 2003 Oct; 89(10):1261. PubMed ID: 12975443
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tachycardia with wide QRS. Limitations of electrocardiographic criteria in patients treated with anti-arrhythmia agents].
    Le Davay M; Victor J; Dupuis JM; Merheb M; Tran P; Tadeï A
    Ann Cardiol Angeiol (Paris); 1994 May; 43(5):253-5. PubMed ID: 8074416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
    Rasheed A; Simpson J; Rosenthal E
    Heart; 2003 Apr; 89(4):470. PubMed ID: 12639886
    [No Abstract]   [Full Text] [Related]  

  • 9. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interstitial pneumopathy due to flecainide].
    Haas M; Pérault MC; Bonnefoy P; Rodeau F; Caron F
    Presse Med; 2001 Jun 16-23; 30(21):1062. PubMed ID: 11471279
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for the use of flecainide in patients with supraventricular arrhythmias.
    Smith W; Crozier I; McAlister H; O'Meeghan T; Stewart F
    N Z Med J; 2000 Oct; 113(1119):420-1. PubMed ID: 11127360
    [No Abstract]   [Full Text] [Related]  

  • 13. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL; Peterson J
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of maternal flecainide concentration in management of fetal supraventricular tachycardia: a step in the right direction.
    Cuneo BF; Benson DW
    Heart Rhythm; 2014 Nov; 11(11):2054-5. PubMed ID: 25128734
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fetal supraventricular tachycardia with anasarca complicating benign extrasystole: treatment with flecainide. Apropos of a case].
    Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
    Arch Mal Coeur Vaiss; 1997 Mar; 90(3):407-10. PubMed ID: 9232080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolysis alters plasma flecainide levels in newborn infants.
    Vento M; Tudela BF; Escrig R; Sáenz P; Sánchez A; Cano A
    Acta Paediatr; 2007 Mar; 96(3):466-8. PubMed ID: 17407483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report].
    Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate.
    Ebenroth ES; Cordes TM; Darragh RK
    Pediatr Cardiol; 2001; 22(6):483-7. PubMed ID: 11894150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flecainide acetate].
    Bordier P; Garrigue S; Clémenty J
    Ann Cardiol Angeiol (Paris); 1996 May; 45(5):263-79. PubMed ID: 8763646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.